Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Thomas Stankovich > Profile

Thomas Stankovich

Affiliations

  • Chief Financial Officer at Reshape Lifesciences Inc. (RSLS), 2024-08-13
  • Chief Financial Officer at Reshape Lifesciences Inc. (RSLS), 2021-06-17
  • Former Vice President & Cfo at Response Genetics Inc (RGDX), 2010-05-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RSLS $1.52 17,702 $26,907.04 23,490 2023-06-30 Filing
RSLS $0.95 1,228 $1,166.60 365,627 2022-05-31 Filing
RSLS $0.94 6,539 $6,146.66 364,399 2022-05-31 Filing
RSLS $0.93 60 $55.80 357,860 2022-05-31 Filing
RSLS $0.92 7,995 $7,355.40 357,800 2022-05-31 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RSLS $0.25 48 $12.00 22,777 2024-05-31 Filing
RSLS $0.17 43 $7.31 22,825 2024-02-29 Filing
RSLS $0.25 42 $10.50 22,868 2023-12-31 Filing
RSLS $0.23 39 $8.97 22,910 2023-11-30 Filing
RSLS $0.27 131 $35.37 22,949 2023-10-25 Filing